Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study-Reference-Cited by-同舟云学术

Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study

Published:2021-02-05 Issue:6 Volume:91 Page:1196-1202
ISSN:1445-1433
Container-title:ANZ Journal of Surgery
language:en
Short-container-title:ANZ Journal of Surgery

Author:

Behrenbruch Corina¹²³^ORCID,Prabhakaran Sowmya²^ORCID,Udayasiri Dilshan²⁴⁵^ORCID,Hollande Frédéric³⁶,Michael Michael¹⁷,Hayes Ian²⁴⁵,Heriot Alexander¹⁸⁹^ORCID,Knowles Brett²⁸,Thomson Benjamin²⁴⁸

Affiliation:

1. Sir Peter MacCallum Department of Oncology, Victorian Comprehensive Cancer Centre The University of Melbourne Melbourne Victoria Australia

2. Department of General Surgical Specialties The Royal Melbourne Hospital Melbourne Victoria Australia

3. Department of Clinical Pathology, Victorian Comprehensive Cancer Centre The University of Melbourne Melbourne Victoria Australia

4. Royal Melbourne Hospital Department of Surgery The University of Melbourne Melbourne Victoria Australia

5. Colorectal Surgery Unit The Royal Melbourne Hospital Melbourne Victoria Australia

6. Centre for Cancer Research, Victorian Comprehensive Cancer Centre The University of Melbourne Melbourne Victoria Australia

7. Department of Medical Oncology Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre Melbourne Victoria Australia

8. Department of Cancer Surgery Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre Melbourne Victoria Australia

9. Department of Surgery, St Vincent's Hospital The University of Melbourne Melbourne Victoria Australia

Publisher

Wiley

Subject

General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ans.16613

Reference24 articles.

1. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer

2. An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients

3. Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone

4. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

5. Hepatic Metastasis from Colorectal Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives;Gastrointestinal Disorders;2023-12-15

2. Neoadjuvant chemotherapy versus upfront surgery for resectable colorectal liver metastases: A systemic review and meta‐analysis;Surgical Practice;2023-11-02

3. Survival of patients with colorectal liver metastases treated with and without preoperative chemotherapy: Nationwide propensity score-matched study;European Journal of Surgical Oncology;2023-09

4. Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases;Journal of Gastrointestinal Surgery;2023-07-19

5. Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study;World Journal of Gastrointestinal Surgery;2022-09-27